Kenvue Inc. $KVUE Shares Newly Bought by VCI Wealth Management LLC

VCI Wealth Management LLC purchased a new stake in Kenvue Inc. (NYSE:KVUE) during the third quarter, according to its most recent disclosure with the SEC. The firm purchased 92,105 shares of the company’s stock, valued at approximately $1,627,000.

Several other institutional investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in Kenvue during the 2nd quarter worth approximately $2,882,279,000. Pentwater Capital Management LP purchased a new position in shares of Kenvue in the second quarter valued at approximately $977,094,000. Bank of America Corp DE purchased a new position in shares of Kenvue in the second quarter valued at approximately $275,204,000. Legal & General Group Plc purchased a new position in shares of Kenvue in the second quarter valued at approximately $253,393,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Kenvue in the second quarter valued at approximately $192,080,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Kenvue Stock Performance

KVUE opened at $19.41 on Tuesday. Kenvue Inc. has a twelve month low of $14.06 and a twelve month high of $20.13. The firm has a market capitalization of $37.28 billion, a PE ratio of 16.38, a PEG ratio of 1.77 and a beta of 0.48. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. The firm’s 50-day moving average price is $18.41 and its 200 day moving average price is $18.20.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Friday, October 30th. The company reported $0.29 EPS for the quarter, meeting analysts’ consensus estimates of $0.29. The company had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.86 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. Kenvue’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.28 EPS. As a group, sell-side analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 2nd. Stockholders of record on Monday, September 21st were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 4.3%. The ex-dividend date was Monday, September 21st. Kenvue’s payout ratio is currently 95.45%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Kenvue in a research note on Friday, September 11th. Wall Street Zen downgraded Kenvue from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. HSBC reduced their price objective on Kenvue from $20.00 to $19.00 and set a “hold” rating for the company in a research note on Monday, August 10th. Barclays raised their price objective on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Finally, UBS Group lifted their target price on shares of Kenvue from $19.00 to $20.00 and gave the stock a “neutral” rating in a research note on Monday. Twelve equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and an average target price of $19.44.

Kenvue Company Profile

Kenvue Inc is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels.

The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson’s and OGX in oral care, baby care and hair care.